United States · FDA National Drug Code directory
Propranolol Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0527-4119_ceeffec9-095b-4081-b268-7869b0685921
- Product NDC
- 0527-4119
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- propranolol hydrochloride
- Labeler
- Lannett Company, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200106
- Source listing expiry
- 20261231
Source-listed ingredients
- PROPRANOLOL HYDROCHLORIDE — 160 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-37) · 0527-4119-37
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-41) · 0527-4119-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →